Ocular Therapeutix, Inc

OCUL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001393434

SEC filings (opens in a new tab)

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Ocular Therapeutix, Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of OCUL: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Of which not filed for Q2 2023	Q2 2023	Change
Holders	127	1	135	+9
Shares	40.5M	8.00K	43.5M	+2.97M (+7.3%)
Value	$213.8M	$42.2K	$224.2M	+$10.4M (+4.9%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Ocular Therapeutix, Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to OCUL in Q2 2023
Institution	Shares	Value	% of portfolio
Sectoral Asset Management Inc	802,680	$4.14M	0.69%
Cormorant Asset Management, LP	645,000	$3.33M	0.19%
AXA S.A.	474,900	$2.45M	0.01%
Essex Investment Management Co LLC	300,977	$1.55M	0.22%
Lynwood Capital Management Inc.	262,500	$1.35M	1.72%
Bank of Montreal	181,509	$936.6K	0.00%
Gsa Capital Partners LLP	118,953	$614.0K	0.06%
Legato Capital Management LLC	116,389	$600.6K	0.08%
Harvest Investment Services, LLC	61,960	$319.7K	0.18%
Lincoln National Corp	57,226	$295.3K	0.01%
Verition Fund Management LLC	54,950	$283.5K	0.00%
HRT Financial LP	54,360	$280.0K	0.00%
Algert Global LLC	49,230	$254.0K	0.01%
Bayesian Capital Management, LP	37,400	$193.0K	0.02%
Daymark Wealth Partners, LLC	25,000	$129.0K	0.01%
Marshall Wace, LLP	15,149	$78.2K	0.00%
Squarepoint Ops LLC	13,689	$70.6K	0.00%
Virtu Financial LLC	13,383	$69.0K	0.01%
Coastal Bridge Advisors, LLC	10,900	$56.2K	0.01%
Profund Advisors LLC	10,728	$55.4K	0.00%
Difesa Capital Management, LP	10,000	$51.6K	0.14%
State of Wyoming	462	$2.38K	0.00%
Quent Capital, LLC	401	$2.07K	0.00%
ICA Group Wealth Management, LLC	300	$1.55K	0.00%
Sofos Investments, Inc.	5	$11	0.00%
Gradient Investments LLC	1	$5	0.00%

Sold out (17)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of OCUL in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
EAM Investors, LLC	224,211	$1.18M
Graham Capital Management, L.P.	77,661	$409.3K
Tejara Capital Ltd	72,457	$381.8K
PDT Partners, LLC	65,350	$344.4K
Cubist Systematic Strategies, LLC	42,989	$226.6K
Group One Trading, L.P.	39,742	$209.4K
SG Americas Securities, LLC	33,849	$178.0K
Axq Capital, LP	25,972	$136.9K
Ergoteles LLC	20,145	$106.2K
Creative Planning	13,889	$73.2K
Quantamental Technologies LLC	13,331	$70.3K
Belpointe Asset Management LLC	12,550	$66.1K
Quantbot Technologies LP	3,254	$17.1K
Fifth Third Bancorp	500	$2.63K
Advisory Services Network, LLC	250	$1.32K
Signaturefd, LLC	192	$1.01K
TCI Wealth Advisors, Inc.	100	$527

Not filed for Q2 2023 yet (1)

Institutions that held Ocular Therapeutix, Inc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OCUL in Q1 2023 that haven't filed for Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Ahrens Investment Partners LLC	8,000	$42.2K